Breaking news on biotech stocks and catalysts which includes FDA announcements, license agreements, and clinical trial data releases.
Amylyx Pharmaceuticals $AMLX stock is testing lower uptrend channel wall support in the wake of regulatory approval of its oral treatment for ALS. Amylyx Pharmaceuticals $AMLX Stock Technical Analysis Amylyx…
89bio $ETNB stock continued in an uptrend on November 14, 2022, as Cantor Fitzgerald predicts a 350% move higher in the stock is coming. Dark Pool Trade in 89bio A…
Fennec Pharmaceuticals $FENC stock continues to move higher in a powerful uptrend channel as of November 1, 2022. The company has launched Pedmark in the U.S. Fennec Pharmaceuticals Announces Commercial…
Verve Therapeutics $VERV stock is testing a downtrend channel breakout going into trading on October 31, 2022. The stock surged higher after a dark pool trade on October 21, 2022.…
AstraZeneca $AZN stock did a double bottom gap up open bounce on October 26, 2022. The reason for the gap up open was the company announcing that capivasertib Phase III…
Phathom Pharmaceuticals $PHAT stock is setting up for a sweet Symmetrical Triangle breakout when the market opens on October 24, 2022. The company announced new data on its acid blocker…
Plus Therapeutics $PSTV, a penny stock trading around $1 a share as of August 18, 2022, announced an incredible $17.6 million award from Texas. Plus Therapeutics Awarded $17.6 Million from…
Novavax $NVAX stock moved 2.8% higher into the close on August 12, 2022, after the company announced that South Korea had approved its COVID-19 protein-based vaccine. Protein vaccines contain proteins…
